Non-antibiotic treatment for infectious diseases
- PMID: 28882020
Non-antibiotic treatment for infectious diseases
Abstract
The abuse and uncontrolled use of antibiotics has resulted in the emergence and spread of resistant bacteria. The utility of conventional antibiotics for the treatment of bacterial infections has become increasingly strained due to increased rates of resistance coupled with reduced rates of development of new agents. As a result, multidrug-resistant, extensively drug-resistant, and pan-drug-resistant bacterial strains are now frequently encountered. This has led to fears of a "post-antibiotic era" in which many bacterial infections could be untreatable. Alternative non-antibiotic treatment strategies need to be explored to ensure that a robust pipeline of effective therapies is available to clinicians. The new therapeutic approaches for bacterial infections (beyond antibiotics) may provide a way to extend the usefulness of current antibiotics in an era of multidrug-resistant (MDR) bacterial infections.
Similar articles
-
Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections.Clin Infect Dis. 2016 Jul 1;63(1):89-95. doi: 10.1093/cid/ciw200. Epub 2016 Mar 29. Clin Infect Dis. 2016. PMID: 27025826 Free PMC article.
-
Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.Int J Mol Sci. 2020 Feb 5;21(3):1061. doi: 10.3390/ijms21031061. Int J Mol Sci. 2020. PMID: 32033477 Free PMC article. Review.
-
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.Curr Top Microbiol Immunol. 2016;398:3-33. doi: 10.1007/82_2016_492. Curr Top Microbiol Immunol. 2016. PMID: 27406189 Review.
-
A Quest to the Therapeutic Arsenal: Novel Strategies to Combat Multidrug- resistant Bacteria.Curr Gene Ther. 2022;22(2):79-88. doi: 10.2174/1566523221666210419084836. Curr Gene Ther. 2022. PMID: 33874870 Review.
-
Neonatal infections due to multi-resistant strains: Epidemiology, current treatment, emerging therapeutic approaches and prevention.Clin Chim Acta. 2015 Dec 7;451(Pt A):71-7. doi: 10.1016/j.cca.2015.02.038. Epub 2015 Mar 4. Clin Chim Acta. 2015. PMID: 25749408 Review.
Cited by
-
Factors influencing receipt of an antibiotic prescription among insured patients in Tanzania: a cross-sectional study.BMJ Open. 2022 Nov 4;12(11):e062147. doi: 10.1136/bmjopen-2022-062147. BMJ Open. 2022. PMID: 36332955 Free PMC article.
-
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.Front Cell Infect Microbiol. 2021 May 17;11:684515. doi: 10.3389/fcimb.2021.684515. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34079770 Free PMC article. Review.
-
Dynamic Relay of Protein-Bound Lipoic Acid in Staphylococcus aureus.J Bacteriol. 2019 Oct 21;201(22):e00446-19. doi: 10.1128/JB.00446-19. Print 2019 Nov 15. J Bacteriol. 2019. PMID: 31451544 Free PMC article.
-
Polymeric Nanoparticles for Antimicrobial Therapies: An Up-To-Date Overview.Polymers (Basel). 2021 Feb 27;13(5):724. doi: 10.3390/polym13050724. Polymers (Basel). 2021. PMID: 33673451 Free PMC article. Review.
-
Antimicrobial Activity of the Iron-Chelator, DIBI, against Multidrug-Resistant Canine Methicillin-Susceptible Staphylococcus pseudintermedius: A Preliminary Study of Four Clinical Strains.Pathogens. 2022 Jun 7;11(6):656. doi: 10.3390/pathogens11060656. Pathogens. 2022. PMID: 35745511 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials